History. A lot of the therapeutic proposals for COVID-19 happen to be connected with adverse consequences, such as the risk of QT interval prolongation and torsades de pointes (TdP). The objective was to determine the use of medications with a possibility of QT interval prolongation in 21 clinics/hospitals in https://directivepublications.org/journal-of-vascular-medicine/